Semler Scientific Q1 2021 Earnings Report
Key Takeaways
Semler Scientific reported a 40% increase in revenues to $13.2 million, a 74% increase in pre-tax net income to $6.0 million, and an 82% increase in net income to $4.9 million, or $0.73 per basic share and $0.60 per diluted share. The company's cash position also strengthened, reaching $26.5 million.
Revenues increased by 40% to $13.2 million.
Pre-tax net income increased by 74% to $6.0 million.
Net income increased by 82% to $4.9 million, or $0.73 per basic share and $0.60 per diluted share.
Cash position increased to $26.5 million.
Semler Scientific
Semler Scientific
Forward Guidance
Semler Scientific anticipates continued profitability and cash generation, along with increased spending to support business growth. The company aims to grow annual revenues faster than annual expenses and maintain profitability.
Positive Outlook
- Continued profitability
- Generation of cash from operating activities
- Increased spending to support anticipated growth
- Intent to grow annual revenues at a faster rate than annual expenses
- Remain profitable